3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
6
Drug Therapy
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Sirolimus
2
Riluzole
2
Oncolytic Virotherapy
2
Ipilimumab
2
Blood Specimen Collection
2
vofatamab
1
tocilizumab
1
saracatinib
1
poly ICLC
1
pertuzumab
1
pazopanib
1
liposomal doxorubicin
1
ixabepilone
1
fludarabine phosphate
1
enzalutamide
1
durvalumab
1
cediranib
1
brodalumab
1
atezolizumab
1
aldesleukin
1
advexin
1
Ultrasonography
1
Tissue Banks
1
TKM-080301
1
Ritonavir
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Radionuclide Imaging
×
Breast
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled